인쇄하기
취소
|
Whien it comes to Hanmi Pharm’s concealment of side effect and delayed notice about the ‘Olita Tab’ clinical trial, the Board of Audit and Inspection of Korea(BAI) will reveal the inspection result on the Ministry of Health and Welfare(MOHW) in the middle of April.
According to a person concerned to the industry, the BAI started the original inspection on the MOHW last December and has conduct...